Skip to Main Content


Skip Nav Destination


In This Issue

In the Spotlight

Science in Society


Research Brief

Clinical panel sequencing analysis of endometrial cancers (EC) identified differences in the prevalence of histologic types, molecular subtypes, and genetic alterations by self-identified race/genetic ancestry, providing insights into EC disparities.

Research Articles

Combined clinical, radiographic, and molecular analyses demonstrate the efficacy of ONC201 in H3K27M-mutant diffuse midline glioma, as ONC201 was shown to disrupt integrated metabolic and epigenetic pathways and reverse pathognomonic H3K27me3 reduction.

NeoCOAST, the first neoadjuvant platform trial of novel immuno-oncology combinations, demonstrates that combined therapies improve responses and immunologic cell activation compared to durvalumab (anti–PD-L1) monotherapy in resectable non–small cell lung cancer.

Targeting the PRMT5/MTA complex selectively inhibits growth of MTAP-deleted preclinical cancer models and demonstrates preliminary clinical activity in MTAP-deleted cancers.

The preclinical profile of STX-478, a mutant-selective, allosteric PI3Kα inhibitor, demonstrates its potential to expand the limited therapeutic window of approved inhibitors and significantly improve outcomes in patients with PI3Kα-mutant cancers.

BCL2 inhibition in type 1 conventional dendritic cells (cDC1) activates the cGAS/STING/type 1 IFN pathway and exerts cDC1-dependent, T cell–mediated anticancer effects, unveiling BCL2 as an endogenous checkpoint of cDC1.

Oncogenesis arises from hijacking a subset of transposable elements active in pluripotent stem cells into regulatory elements for lineage-specific transcription factors, such as the androgen receptor in prostate cancer.

News in Brief

Research Watch

Genetic Predisposition
Ovarian Cancer
Structural Biology
Drug Resistance
Hepatocellular Carcinoma


Close Modal

or Create an Account

Close Modal
Close Modal